Self-care for head and neck cancer survivors with lymphedema and fibrosis: study protocol for a randomized controlled trial

Jie Deng, Mary S Dietrich, Barbara Murphy, Jie Deng, Mary S Dietrich, Barbara Murphy

Abstract

Background: Head and neck cancer (HNC) patients are at high risk for developing lymphedema and fibrosis (LEF) following cancer treatment. Once HNC patients develop LEF, they need to conduct life-long self-care to slow LEF progression and reduce associated symptom burden and functional deficits. Data demonstrate that inadequate LEF self-care may be a potentially remediable issue. The objective of this study is to explore the feasibility and preliminary efficacy of an Information-Motivation-Behavioral (IMB) Skills model-driven self-care program (SCP) to improve LEF management and reduce LEF-related symptom burden and functional impairments.

Methods/design: This is a three-arm, prospective, randomized controlled clinical trial to compare: Group 1 - Usual Care, Group 2 - Usual Care Plus LEF-SCP, and Group 3 - Usual Care Plus LEF-SCP Plus Follow-Up. Participants will be HNC survivors aged > 18 years of age, who meet predefined inclusion and exclusion criteria. A sample size of 75 participants is targeted. Interventions will be provided by trained staff. The study assessments for all groups will take place at five points: study entry then 3, 6, 9, and 12 months post enrollment. Outcome measures include: (1) feasibility (barriers to implementation, safety, and satisfaction) of the proposed intervention; (2) self-efficacy and adherence to self-care; and (3) preliminary efficacy (LEF progression, symptom burden, and functional status) of the proposed intervention.

Discussion: This will be the first study to evaluate the feasibility of a LEF-SCP in the HNC population and its impact on self-efficacy and adherence. Furthermore, it will evaluate the potential benefit of routine follow-up on adherence and fidelity to the self-care protocol. We expect that the trial will provide evidence supporting the feasibility of a LEF self-care program. In addition, we anticipate that preliminary data will support improved outcomes including increased adherence and fidelity, and decreased LEF-associated symptoms.

Trial registration: ClinicalTrials.gov, a service of the US National Institute of Health (NCT03030859). Registered on 22 January 2017.

Keywords: Fibrosis; Head and neck cancer; Lymphedema; Self-care; Self-management; Survivorship.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Standard Protocol Items: Recommendation for Interventional Trials (SPIRIT) Figure

References

    1. American Cancer Society. Cancer facts and figures 2010. Atlanta, GA: American Cancer Society; 2010. Accessed: 1 Mar 2016. Available from:
    1. American Cancer Society. Cancer facts and figures 2019. Atlanta, GA: American Cancer Society; 2019. Accessed: 1 Mar 2019. Available from:
    1. Gooi Z, Chan JY, Fakhry C. The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer. Laryngoscope. 2016;126(4):894–900. doi: 10.1002/lary.25767.
    1. Friedman JM, Stavas MJ, Cmelak AJ. Clinical and scientific impact of human papillomavirus on head and neck cancer. World J Clin Oncol. 2014;5(4):781–791. doi: 10.5306/wjco.v5.i4.781.
    1. Haddad RI, Limaye S. Overview of approach to long-term survivors of head and neck cancer. In: Post TW, (Ed), UpToDate. Accessed 1 Mar 2016. Waltham, MA: UpToDate; 2016.
    1. Vokes EE, Kies MS, Haraf DJ, Stenson K, List M, Humerickhouse R, Dolan ME, Pelzer H, Sulzen L, Witt ME, Hsieh YC, Mittal BB, Weichselbaum RR. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol. 2000;18(8):1652–1661. doi: 10.1200/JCO.2000.18.8.1652.
    1. Deng J, Ridner SH, Dietrich MS, Wells N, Wallston KA, Sinard RJ, Cmelak AJ, Murphy BA. Prevalence of secondary lymphedema in patients with head and neck cancer. J Pain Symptom Manag. 2012;43(2):244–252. doi: 10.1016/j.jpainsymman.2011.03.019.
    1. Deng J, Ridner SH, Wells N, Dietrich MS, Murphy BA. Development and preliminary testing of head and neck cancer related external lymphedema and fibrosis assessment criteria. Eur J Oncol Nurs. 2015;19(1):75–80. doi: 10.1016/j.ejon.2014.07.006.
    1. Smith BG, Lewin JS. Lymphedema management in head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2010;18(3):153–158. doi: 10.1097/MOO.0b013e3283393799.
    1. Deng J, Murphy BA, Dietrich MS, Wells N, Wallston KA, Sinard RJ, Cmelak AJ, Gilbert J, Ridner SH. Impact of secondary lymphedema after HNC treatment on symptoms, functional status, and quality of life. Head Neck. 2013;35(7):1026–1035. doi: 10.1002/hed.23084.
    1. Deng J, Ridner SH, Murphy BA. Lymphedema in patients with head and neck cancer. Oncol Nurs Forum. 2011;38(1):E1–E10. doi: 10.1188/11.ONF.E1-E10.
    1. Murphy BA, Ridner SH. Late effect laryngeal oedema/lymphoedema. J Lymphoedema. 2010;5(2):92–93.
    1. Földi M, Földi E, Strössenreuther RHK, Kubik S, editors. Földi's textbook of lymphology: for physicians and lymphedema therapists. 2. Muchen: Mosby; 2006.
    1. Zuther J. Lymphedema management: the comprehensive guide for practitioners. 2. New York: Thieme; 2009.
    1. Jeffs E, Huit M. Treatment and outcomes of head and neck oedema referrals to a hospital-based lymphoedema service. Br J Community Nurs. 2015;Suppl:S6–13. doi: 10.12968/bjcn.2015.20.Sup4.S6.
    1. McGarvey AC, Osmotherly PG, Hoffman GR, Chiarelli PE. Lymphoedema following treatment for head and neck cancer: Impact on patients, and beliefs of health professionals. Eur J Cancer Care (Engl) 2014;23(3):317–327. doi: 10.1111/ecc.12134.
    1. Cohen EE, LaMonte SJ, Erb NL, Beckman KL, Sadeghi N, Hutcheson KA, Stubblefield MD, Abbott DM, Fisher PS, Stein KD, Lyman GH, Pratt-Chapman ML. American Cancer Society Head and Neck Cancer Survivorship Care Guideline. CA Cancer J Clin. 2016; [Epub ahead of print] Review.
    1. Lymphoedema Framework . Best practice of the management of lymphoedema. International consensus. London: MEP Ltd; 2006.
    1. Lee B-B, Bergan JJ, Rockson SG. Lymphedema: a concise compendium of the theory and practice. London: Springer; 2011.
    1. Ridner SH, Fu MR, Wanchai A, Stewart BR, Armer JM, Cormier JN. Self-management of lymphedema: a systematic review of the literature from 2004 to 2011. Nurs Res. 2012;61(4):291–299. doi: 10.1097/NNR.0b013e31824f82b2.
    1. Deng J, Sinard RJ, Murphy BA. Patient experience of head and neck lymphedema therapy: a qualitative study. Support Care Cancer. 2018;30 [Epub ahead of print].
    1. Chang SJ, Choi S, Se-An K, Song M. Intervention strategies based on information-motivation-behavioral skills model for health behavior change: a systematic review. Asian Nurs Res. 2014;8:172–181. doi: 10.1016/j.anr.2014.08.002.
    1. Fisher WA, Fisher JD, Harman J. The information-motivation-behavioral skills model: a general social psychological approach to understanding and promoting health behavior. In: Suls J, Wallston KA, editors. Social psychological foundations of health and illness. Malden: Blackwell; 2003. pp. 82–106.
    1. Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin J, Dickersin K, Hróbjartsson A, Schulz KF, Parulekar WR, Krleža-Jerić K, Laupacis A, Moher D. SPIRIT 2013 Explanation and Elaboration: Guidance for protocols of clinical trials. BMJ. 2013;346:e7586. doi: 10.1136/bmj.e7586.
    1. U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Events v4.0 (CTCAE). 2010. Accessed: 10 Mar 2016. Available from: .
    1. Smith MS, Wallston KA, Smith CA. The development and validation of the Perceived Health Competence Scale. Health Educ Res. 1995;10(1):51–64. doi: 10.1093/her/10.1.51.
    1. Wallston KA, Rothman RL, Cherrington A. Psychometric properties of the Perceived Diabetes Self-Management Scale (PDSMS) J Behav Med. 2007;30(5):395–401. doi: 10.1007/s10865-007-9110-y.
    1. Wallston KA, Osborn CY, Wagner LJ, Hilker KA. The Perceived Medical Condition Self-Management Scale applied to persons with HIV/AIDS. J Health Psychol. 2011;16(1):109–115. doi: 10.1177/1359105310367832.
    1. Patterson JM, Hildreth A, Wilson JA. Measuring edema in irradiated head and neck cancer patients. Ann Otol Rhinol Laryngol. 2007;116(8):559–564. doi: 10.1177/000348940711600801.
    1. Deng J, Ridner SH, Murphy BA, Dietrich MS. Preliminary development of a lymphedema symptom assessment scale for patients with head and neck cancer. Support Care Cancer. 2012;20(8):1911–1918. doi: 10.1007/s00520-011-1294-6.
    1. Deng J, Murphy BA, Dietrich MS, Sinard RJ, Mannion K, Ridner SH. Differences of symptoms in head and neck cancer patients with and without lymphedema. Support Care Cancer. 2016;24(3):1305–1316. doi: 10.1007/s00520-015-2893-4.
    1. Murphy BA, Dietrich MS, Wells N, Dwyer K, Ridner SH, Silver HJ, Gilbert J, Chung CH, Cmelak A, Burkey B, Yarbrough WG, Sinard R, Netterville J. Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: a tool to assess symptom burden in patients treated with chemoradiation. Head Neck. 2010;32(1):26–37.
    1. Cooperstein E, Gilbert J, Epstein JB, Dietrich MS, Bond SM, Ridner SH, Wells N, Cmelak A, Murphy BA. Vanderbilt Head and Neck Symptom Survey Version 2.0: Report of the development and initial testing of a subscale for assessment of oral health. Head Neck. 2012;34(6):797–804. doi: 10.1002/hed.21816.
    1. Kolnick L, Deng J, Epstein JB, Migliorati CA, Rezk J, Dietrich MS, Murphy BA. Associations of oral health items of the Vanderbilt Head and Neck Symptom Survey with a dental health assessment. Oral Oncol. 2014;50(2):135–140. doi: 10.1016/j.oraloncology.2013.10.019.
    1. George JW, Fennema J, Maddox A, Nessler M, Skaggs CD. The effect of cervical spine manual therapy on normal mouth opening in asymptomatic subjects. J Chiropr Med. 2007;6(4):141–145. doi: 10.1016/j.jcme.2007.08.001.
    1. Shaffer SM, Brismée JM, Sizer PS, Courtney CA. Temporomandibular disorders. Part 1: anatomy and examination/diagnosis. J Man Manip Ther. 2014;22(1):2–12. doi: 10.1179/2042618613Y.0000000060.
    1. Williams MA, McCarthy CJ, Chorti A, Cooke MW, Gates S. A systematic review of reliability and validity studies of methods for measuring active and passive cervical range of motion. J Manip Physiol Ther. 2010;33(2):138–155. doi: 10.1016/j.jmpt.2009.12.009.
    1. . Evaluation and Testing—Goniometers. HOSPEQ, Inc, 2016. Accessed: 1 Mar 2016. Available from:
    1. Centers for Disease Control and Prevention. Universal data collection (UDC) joint range of motion video rom measurement procedures: Shoulder flexion. 2010. Accessed: 1 Mar 2016. Available from:

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner